Kiora Pharmaceuticals(KPRX)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KPRX Kiora Pharmaceuticals

休市中 12-12 16:00:00 EST

2.14

+0.00

-0.23%

盘后2.13

+0.00-0.23%

19:59 EST

最高2.18	最低2.10	成交量1.32万
今开2.18	昨收2.14	日振幅3.71%
总市值785.24万	流通市值723.83万	总股本367.79万
成交额2.81万	换手率0.39%	流通股本339.03万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"KPRX","market":"US","secType":"STK","nameCN":"Kiora Pharmaceuticals","latestPrice":2.135,"timestamp":1765573200000,"preClose":2.14,"halted":0,"volume":13201,"hourTrading":{"tag":"盘后","latestPrice":2.13,"preClose":2.135,"latestTime":"19:59 EST","volume":153,"amount":325.935,"timestamp":1765587587118},"delay":0,"floatShares":3390299,"shares":3677935,"eps":-2.051742,"marketStatus":"休市中","change":-0.005,"latestTime":"12-12 16:00:00 EST","open":2.18,"high":2.18,"low":2.1007,"amount":28052.295292900002,"amplitude":0.037056,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.051742,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"listingDate":1438315200000,"exchange":"NASDAQ","adjPreClose":2.14,"postHourTrading":{"tag":"盘后","latestPrice":2.13,"preClose":2.135,"latestTime":"19:59 EST","volume":153,"amount":325.935,"timestamp":1765587587118},"volumeRatio":0.5005155634427376},"requestUrl":"/m/hq/s/KPRX/tweets","defaultTab":"tweets","newsList":[{"id":"2587753764","title":"Kiora Pharmaceuticals, Inc.盘中异动 股价大涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2587753764","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587753764?lang=zh_cn&edition=full","pubTime":"2025-11-29 00:12","pubTimestamp":1764346346,"startTime":"0","endTime":"0","summary":"北京时间2025年11月29日00时12分，Kiora Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.32%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Pasithea Therapeutics Corp.、Liminatus Pharma Inc C/Wts 30/04/2030 涨幅较大，Aditxt, Inc.、Pasithea Therapeutics Corp.、Cdt Equity Inc.较为活跃，换手率分别为4043.28%、1738.80%、249.27%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Pasithea Therapeutics Corp.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为111.14%、67.92%、40.72%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251129001226952015f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251129001226952015f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHCW","BK4007","KPRX","KPHMW"],"gpt_icon":0},{"id":"2558866595","title":"Kiora Pharmaceuticals, Inc.盘中异动 股价大涨5.08%报2.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558866595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558866595?lang=zh_cn&edition=full","pubTime":"2025-08-11 21:32","pubTimestamp":1754919125,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时32分，Kiora Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.08%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Equillium, Inc.、Entero Therapeutics Inc.、Bioxcel Therapeutics, Inc.涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Io Biotech, Inc.较为活跃，换手率分别为1752.27%、210.41%、76.52%，振幅较大的相关个股有Entero Therapeutics Inc.、Equillium, Inc.、Io Biotech, Inc.，振幅分别为33.16%、32.31%、11.88%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811213205a4821661&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811213205a4821661&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHCW","KPRX","BK4007","KPHMW"],"gpt_icon":0},{"id":"2558457624","title":"Kiora Pharmaceuticals, Inc.盘中异动 大幅下挫5.02%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558457624","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558457624?lang=zh_cn&edition=full","pubTime":"2025-08-09 00:59","pubTimestamp":1754672357,"startTime":"0","endTime":"0","summary":"北京时间2025年08月09日00时59分，Kiora Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.02%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，Hyperion Defi, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Alector, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Biovie Inc.、Onconetix, Inc.较为活跃，换手率分别为627.70%、165.55%、101.64%，振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、180 Life Sciences Corp C/Wts 07/11/2025、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为75.81%、73.00%、46.49%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080900591794d820bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080900591794d820bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPRX","BK4007","KPHMW","KPHCW"],"gpt_icon":0},{"id":"2556879633","title":"Kiora Pharmaceuticals, Inc.盘中异动 早盘股价大跌9.06%报2.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556879633","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556879633?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:32","pubTimestamp":1754314367,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日21时32分，Kiora Pharmaceuticals, Inc.股票出现波动，股价快速下跌9.06%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Psyence Biomedical Ltd.、Soligenix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为2265.81%、810.15%、390.96%，振幅较大的相关个股有Psyence Biomedical Ltd.、凯信远达、Bioxcel Therapeutics, Inc.，振幅分别为28.60%、15.35%、13.50%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804213247a4749005&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804213247a4749005&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPRX","KPHMW","BK4007","KPHCW"],"gpt_icon":0},{"id":"2555572190","title":"Kiora Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.12%报2.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555572190","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555572190?lang=zh_cn&edition=full","pubTime":"2025-07-29 22:52","pubTimestamp":1753800742,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日22时52分，Kiora Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.12%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Salarius Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Sarepta Therapeutics, Inc.涨幅较大，Scinai Immunotherapeutics Ltd、Salarius Pharmaceuticals, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为5082.98%、2935.28%、1564.52%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、180 Life Sciences Corp.，振幅分别为112.00%、111.54%、75.60%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729225222a6c8103c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729225222a6c8103c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHCW","KPHMW","BK4007","KPRX"],"gpt_icon":0},{"id":"2554975495","title":"凯奥拉制药公司获得KIO-104用于眼部炎症疾病的美国专利Kiora Pharmaceuticals Secures U.S. Patent for KIO-104 in Ocular Inflammatory Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2554975495","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554975495?lang=zh_cn&edition=full","pubTime":"2025-07-25 15:26","pubTimestamp":1753428360,"startTime":"0","endTime":"0","summary":"这种针对性机制使KIO-104成为炎症性视网膜疾病的一个有前景的候选药物。According to the company, the newly granted patent will extend KIO-104’s market exclusivity through 2043, providing long-term protection for its potential commercial use.据该公司称，新授予的专利将延长KIO-104的市场独占期至2043年，为其潜在的商业用途提供长期保护。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072515292394ba0551&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072515292394ba0551&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KIO","BK4007","KPRX"],"gpt_icon":0},{"id":"2548855595","title":"Kiora Pharmaceuticals, Inc.7月1日成交额为4.45万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548855595","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548855595?lang=zh_cn&edition=full","pubTime":"2025-07-02 11:07","pubTimestamp":1751425647,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日，Kiora Pharmaceuticals, Inc.成交额为4.45万美元，成交额较昨日减少78.67%，当日成交量为1.58万股。Kiora Pharmaceuticals, Inc.于2025年7月1日跌2.08%，报2.82美元，该股过去5个交易日跌8.14%，年初至今跌14.55%，过去60日跌0.35%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-01|4.45万|-78.67%|1.58万|#|2025-06-30|20.84万|120.30%|7.46万|#|2025-06-27|9.46万|-14.63%|3.17万|#|2025-06-26|11.08万|48.13%|3.66万|#|2025-06-25|7.48万|-33.19%|2.45万|Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702110730a7299816&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702110730a7299816&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHMW","BK4007","KPRX","KPHCW"],"gpt_icon":0},{"id":"2548023415","title":"Kiora Pharmaceuticals, Inc.6月30日成交额为20.84万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548023415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548023415?lang=zh_cn&edition=full","pubTime":"2025-07-01 10:56","pubTimestamp":1751338613,"startTime":"0","endTime":"0","summary":"美东时间2025年6月30日，Kiora Pharmaceuticals, Inc.成交额为20.84万美元，成交额较昨日增加120.30%，当日成交量为7.46万股。Kiora Pharmaceuticals, Inc.于2025年6月30日跌0.69%，报2.88美元，该股过去5个交易日跌7.99%，年初至今跌12.73%，过去60日涨2.49%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-30|20.84万|120.30%|7.46万|#|2025-06-27|9.46万|-14.63%|3.17万|#|2025-06-26|11.08万|48.13%|3.66万|#|2025-06-25|7.48万|-33.19%|2.45万|#|2025-06-24|11.20万|-10.78%|3.60万|Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701105701a72760fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701105701a72760fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","KPHMW","KPHCW","KPRX"],"gpt_icon":0},{"id":"2546775648","title":"Kiora Pharmaceuticals, Inc.6月27日成交额为9.46万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546775648","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546775648?lang=zh_cn&edition=full","pubTime":"2025-06-28 11:05","pubTimestamp":1751079919,"startTime":"0","endTime":"0","summary":"美东时间2025年6月27日，Kiora Pharmaceuticals, Inc.成交额为9.46万美元，成交额较昨日减少14.63%，当日成交量为3.17万股。Kiora Pharmaceuticals, Inc.于2025年6月27日跌4.29%，报2.9美元，该股过去5个交易日跌9.38%，年初至今跌12.12%，过去60日跌1.02%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-27|9.46万|-14.63%|3.17万|#|2025-06-26|11.08万|48.13%|3.66万|#|2025-06-25|7.48万|-33.19%|2.45万|#|2025-06-24|11.20万|-10.78%|3.60万|#|2025-06-23|12.55万|-78.37%|4.06万|Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628110524a721f8f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628110524a721f8f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPRX","KPHMW","BK4007","KPHCW"],"gpt_icon":0},{"id":"2546274952","title":"Kiora Pharmaceuticals, Inc.6月25日成交额为7.48万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546274952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546274952?lang=zh_cn&edition=full","pubTime":"2025-06-26 11:09","pubTimestamp":1750907384,"startTime":"0","endTime":"0","summary":"美东时间2025年6月25日，Kiora Pharmaceuticals, Inc.成交额为7.48万美元，成交额较昨日减少33.19%，当日成交量为2.45万股。Kiora Pharmaceuticals, Inc.于2025年6月25日跌1.3%，报3.03美元，该股过去5个交易日涨3.06%，年初至今跌8.18%，过去60日跌1.62%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-25|7.48万|-33.19%|2.45万|#|2025-06-24|11.20万|-10.78%|3.60万|#|2025-06-23|12.55万|-78.37%|4.06万|#|2025-06-20|58.05万|58.83%|18.61万|#|2025-06-18|36.54万|58.13%|12.28万|Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626110952a4be5f85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626110952a4be5f85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHCW","KPHMW","BK4007","KPRX"],"gpt_icon":0},{"id":"2546406266","title":"Kiora Pharmaceuticals, Inc.6月24日成交额为11.20万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546406266","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546406266?lang=zh_cn&edition=full","pubTime":"2025-06-25 11:09","pubTimestamp":1750820960,"startTime":"0","endTime":"0","summary":"美东时间2025年6月24日，Kiora Pharmaceuticals, Inc.成交额为11.20万美元，成交额较昨日减少10.78%，当日成交量为3.60万股。Kiora Pharmaceuticals, Inc.于2025年6月24日跌1.92%，报3.07美元，该股过去5个交易日涨1.99%，年初至今跌6.97%，过去60日涨1.66%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-24|11.20万|-10.78%|3.60万|#|2025-06-23|12.55万|-78.37%|4.06万|#|2025-06-20|58.05万|58.83%|18.61万|#|2025-06-18|36.54万|58.13%|12.28万|#|2025-06-17|23.11万|170.01%|7.82万|Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625110922a71c3b3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625110922a71c3b3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPRX","KPHMW","BK4007","KPHCW"],"gpt_icon":0},{"id":"2545475685","title":"Kiora Pharmaceuticals, Inc.6月23日成交额为12.55万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545475685","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545475685?lang=zh_cn&edition=full","pubTime":"2025-06-24 11:08","pubTimestamp":1750734511,"startTime":"0","endTime":"0","summary":"美东时间2025年6月23日，Kiora Pharmaceuticals, Inc.成交额为12.55万美元，成交额较昨日减少78.37%，当日成交量为4.06万股。Kiora Pharmaceuticals, Inc.于2025年6月23日跌2.19%，报3.13美元，该股过去5个交易日涨3.64%，年初至今跌5.15%，过去60日涨4.68%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-23|12.55万|-78.37%|4.06万|#|2025-06-20|58.05万|58.83%|18.61万|#|2025-06-18|36.54万|58.13%|12.28万|#|2025-06-17|23.11万|170.01%|7.82万|#|2025-06-16|8.56万|-23.70%|2.83万|Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624110842a71a7143&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624110842a71a7143&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHCW","KPHMW","KPRX","BK4007"],"gpt_icon":0},{"id":"2544133048","title":"Kiora Pharmaceuticals, Inc.6月18日成交额为36.54万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544133048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544133048?lang=zh_cn&edition=full","pubTime":"2025-06-19 11:02","pubTimestamp":1750302151,"startTime":"0","endTime":"0","summary":"美东时间2025年6月18日，Kiora Pharmaceuticals, Inc.成交额为36.54万美元，成交额较昨日增加58.13%，当日成交量为12.28万股。Kiora Pharmaceuticals, Inc.于2025年6月18日涨2.72%，报3.02美元，该股过去5个交易日跌4.43%，年初至今跌8.48%，过去60日跌5.63%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-18|36.54万|58.13%|12.28万|#|2025-06-17|23.11万|170.01%|7.82万|#|2025-06-16|8.56万|-23.70%|2.83万|#|2025-06-13|11.22万|-48.91%|3.64万|#|2025-06-12|21.95万|-19.81%|7.17万|Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619110240a711a5e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619110240a711a5e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","KPHCW","KPHMW","KPRX"],"gpt_icon":0},{"id":"2542856590","title":"Kiora Pharmaceuticals, Inc.6月11日成交额为27.38万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542856590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542856590?lang=zh_cn&edition=full","pubTime":"2025-06-12 10:54","pubTimestamp":1749696871,"startTime":"0","endTime":"0","summary":"美东时间2025年6月11日，Kiora Pharmaceuticals, Inc.成交额为27.38万美元，成交额较昨日减少18.50%，当日成交量为8.51万股。Kiora Pharmaceuticals, Inc.于2025年6月11日跌5.39%，报3.16美元，该股过去5个交易日跌0.94%，年初至今跌4.24%，过去60日跌3.95%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-11|27.38万|-18.50%|8.51万|#|2025-06-10|33.59万|-29.43%|10.17万|#|2025-06-09|47.60万|-31.78%|14.92万|#|2025-06-06|69.78万|-36.32%|23.19万|#|2025-06-05|109.58万|-55.93%|35.57万|Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612105434a4a44e57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612105434a4a44e57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPRX","BK4007","KPHMW","KPHCW"],"gpt_icon":0},{"id":"2542378697","title":"Kiora Pharmaceuticals, Inc.6月10日成交额为33.59万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542378697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542378697?lang=zh_cn&edition=full","pubTime":"2025-06-11 10:42","pubTimestamp":1749609746,"startTime":"0","endTime":"0","summary":"美东时间2025年6月10日，Kiora Pharmaceuticals, Inc.成交额为33.59万美元，成交额较昨日减少29.43%，当日成交量为10.17万股。Kiora Pharmaceuticals, Inc.于2025年6月10日涨2.77%，报3.34美元，该股过去5个交易日跌14.36%，年初至今涨1.21%，过去60日涨3.09%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-10|33.59万|-29.43%|10.17万|#|2025-06-09|47.60万|-31.78%|14.92万|#|2025-06-06|69.78万|-36.32%|23.19万|#|2025-06-05|109.58万|-55.93%|35.57万|#|2025-06-04|248.68万|-97.27%|76.90万|Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611104233a4a2c8f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611104233a4a2c8f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHMW","KPHCW","BK4007","KPRX"],"gpt_icon":0},{"id":"2542337843","title":"Kiora Pharmaceuticals, Inc.盘中异动 急速拉升5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542337843","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542337843?lang=zh_cn&edition=full","pubTime":"2025-06-09 22:44","pubTimestamp":1749480291,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日22时44分，Kiora Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.52%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Synaptogenix, Inc.、Dermata Therapeutics Inc C/Wts 涨幅较大，Synaptogenix, Inc.、Pmgc Holdings Inc.、Nucana Plc较为活跃，换手率分别为2405.75%、1700.26%、1221.99%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Estrella Immunopharma Inc C/Wts 29/09/2028、Synaptogenix, Inc.，振幅分别为362.18%、83.98%、79.24%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092244519777f9c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092244519777f9c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHMW","BK4007","KPRX","KPHCW"],"gpt_icon":0},{"id":"2541897912","title":"Kiora Pharmaceuticals, Inc.6月6日成交额为69.78万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541897912","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541897912?lang=zh_cn&edition=full","pubTime":"2025-06-07 10:41","pubTimestamp":1749264060,"startTime":"0","endTime":"0","summary":"美东时间2025年6月6日，Kiora Pharmaceuticals, Inc.成交额为69.78万美元，成交额较昨日减少36.32%，当日成交量为23.19万股。Kiora Pharmaceuticals, Inc.于2025年6月6日跌0.32%，报3.08美元，该股过去5个交易日涨3.36%，年初至今跌6.67%，过去60日跌5.52%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-06|69.78万|-36.32%|23.19万|#|2025-06-05|109.58万|-55.93%|35.57万|#|2025-06-04|248.68万|-97.27%|76.90万|#|2025-06-03|9099.94万|1149462.80%|2458.96万|#|2025-06-02|7916.00|-66.03%|2737.00|Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250607104110a6fdd906&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250607104110a6fdd906&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHMW","BK4007","KPHCW","KPRX"],"gpt_icon":0},{"id":"2541886333","title":"Kiora Pharmaceuticals, Inc.6月5日成交额为109.58万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541886333","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541886333?lang=zh_cn&edition=full","pubTime":"2025-06-06 10:40","pubTimestamp":1749177658,"startTime":"0","endTime":"0","summary":"美东时间2025年6月5日，Kiora Pharmaceuticals, Inc.成交额为109.58万美元，成交额较昨日减少55.93%，当日成交量为35.57万股。Kiora Pharmaceuticals, Inc.于2025年6月5日跌3.13%，报3.09美元，该股过去5个交易日涨3.0%，年初至今跌6.36%，过去60日跌0.96%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-05|109.58万|-55.93%|35.57万|#|2025-06-04|248.68万|-97.27%|76.90万|#|2025-06-03|9099.94万|1149462.80%|2458.96万|#|2025-06-02|7916.00|-66.03%|2737.00|#|2025-05-30|2.33万|17.98%|7616.00|Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606104100a49c3f79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606104100a49c3f79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPRX","KPHCW","KPHMW","BK4007"],"gpt_icon":0},{"id":"2517416736","title":"Kiora Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517416736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517416736?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:23","pubTimestamp":1741278229,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时23分，Kiora Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.36%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.涨幅较大，Aeon Biopharma, Inc.、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为2968.68%、2019.90%、172.52%，振幅较大的相关个股有Tonix Pharmaceuticals Holding Corp.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Aeon Biopharma, Inc.，振幅分别为71.44%、68.33%、67.37%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307002350963c6223&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307002350963c6223&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHCW","KPHMW","BK4007","KPRX"],"gpt_icon":0},{"id":"2517017929","title":"Kiora Pharmaceuticals, Inc.盘中异动 临近收盘大幅上涨7.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517017929","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517017929?lang=zh_cn&edition=full","pubTime":"2025-03-06 05:01","pubTimestamp":1741208492,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日05时01分，Kiora Pharmaceuticals, Inc.股票出现波动，股价快速拉升7.46%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.85%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Chimerix, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为1004.53%、326.36%、323.40%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为974.63%、82.59%、54.27%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306050133989d9908&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306050133989d9908&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHCW","BK4007","KPRX","KPHMW"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kiorapharma.com","stockEarnings":[{"period":"1week","weight":0.0517},{"period":"1month","weight":-0.0738},{"period":"3month","weight":-0.1913},{"period":"6month","weight":-0.293},{"period":"1year","weight":-0.3921},{"period":"ytd","weight":-0.353}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kiora Pharmaceuticals, Inc.于2004年12月26日以EyeGate Pharmaceuticals, Inc.的名义成立为特拉华州公司，并于2021年11月8日起更名为Kiora Pharmaceuticals, Inc.。该公司是一家临床阶段的专业制药公司专注于开发和商业化用于治疗眼疾的疗法和药物输送。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.075351},{"month":2,"riseRate":0.5,"avgChangeRate":0.126042},{"month":3,"riseRate":0.1,"avgChangeRate":-0.128173},{"month":4,"riseRate":0.5,"avgChangeRate":0.006257},{"month":5,"riseRate":0.3,"avgChangeRate":-0.081341},{"month":6,"riseRate":0.1,"avgChangeRate":-0.162246},{"month":7,"riseRate":0.2,"avgChangeRate":-0.159113},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.112604},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.015303},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.032629},{"month":11,"riseRate":0.363636,"avgChangeRate":0.072057},{"month":12,"riseRate":0.454545,"avgChangeRate":0.055568}],"exchange":"NASDAQ","name":"Kiora Pharmaceuticals","nameEN":"Kiora Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kiora Pharmaceuticals(KPRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kiora Pharmaceuticals(KPRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kiora Pharmaceuticals,KPRX,Kiora Pharmaceuticals股票,Kiora Pharmaceuticals股票老虎,Kiora Pharmaceuticals股票老虎国际,Kiora Pharmaceuticals行情,Kiora Pharmaceuticals股票行情,Kiora Pharmaceuticals股价,Kiora Pharmaceuticals股市,Kiora Pharmaceuticals股票价格,Kiora Pharmaceuticals股票交易,Kiora Pharmaceuticals股票购买,Kiora Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kiora Pharmaceuticals(KPRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kiora Pharmaceuticals(KPRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况